Director Leone Patterson resigns from Eliem Therapeutics board

Climb Bio, Inc.

Leone Patterson resigned from the Board effective Jan 19, 2023, citing no disagreement on operations.
Board size reduced from 7 to 6 directors.
Audit Committee reconstituted: Adam Rosenberg (Chair), Simon Tate, Judith Dunn.
Nominating and Corp Gov Committee: Simon Tate (Chair), Liam Ratcliffe.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Leone Patterson

Director

CLYM · Climb Bio, Inc.

Effective: 2023-01-19
Filed: January 24, 2023, 6:59 PM ET

On January 19, 2023, Leone Patterson notified Eliem Therapeutics, Inc. (Eliem, or the Company) of her decision to resign from the Board of Directors of the Company (the Board), effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Leone Patterson resigned as Director at Climb Bio, Inc..

Action: resigned
Role: Director

Exact text from the filing

On January 19, 2023, Leone Patterson notified Eliem Therapeutics, Inc. (Eliem, or the Company) of her decision to resign from the Board of Directors of the Company (the Board), effective immediately.

View on SEC.gov

Climb Bio, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-23-014221

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.